EU Commission Drops Allegations Against Merck KGaA in Merger Case
By Cecilia Butini
German pharmaceutical company Merck KGaA said Wednesday that the
European Commission will not pursue allegations that it breached
European Union merger rules when it acquired Sigma-Aldrich in
Existing antitrust proceedings against Sigma-Aldrich, a German
chemicals and life-sciences company, are still standing, the
company said citing information from the Commission.
The European Commission concluded in a 2017 Statement of
Objections that Merck KGaA and Sigma-Aldrich failed to provide full
information related to their merger, saying that a packaging
technology that Sigma-Aldrich developed needed to be taken into
account in the acquisition process.
Merck KGaA said it has cooperated with the European Commission
since the beginning of the proceedings and that it expects the
situation to be resolved satisfactorily.
Write to Cecilia Butini at firstname.lastname@example.org
(END) Dow Jones Newswires
July 01, 2020 11:17 ET (15:17 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.